A detailed history of Pittenger & Anderson Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pittenger & Anderson Inc holds 47,387 shares of MRK stock, worth $4.89 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
47,387
Previous 46,962 0.9%
Holding current value
$4.89 Million
Previous $5.81 Million 7.43%
% of portfolio
0.22%
Previous 0.25%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$111.15 - $128.97 $47,238 - $54,812
425 Added 0.9%
47,387 $5.38 Million
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $25,379 - $27,256
205 Added 0.44%
46,962 $5.81 Million
Q4 2023

Feb 02, 2024

BUY
$100.18 - $109.02 $13,223 - $14,390
132 Added 0.28%
46,757 $5.1 Million
Q3 2023

Nov 02, 2023

SELL
$102.95 - $114.33 $241,417 - $268,103
-2,345 Reduced 4.79%
46,625 $4.8 Million
Q2 2023

Aug 09, 2023

BUY
$108.61 - $118.38 $96,119 - $104,766
885 Added 1.84%
48,970 $5.65 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $6,691 - $7,465
65 Added 0.14%
48,085 $5.12 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $84,816 - $108,746
970 Added 2.06%
48,020 $5.33 Million
Q3 2022

Nov 15, 2022

BUY
$84.53 - $94.96 $59,593 - $66,946
705 Added 1.52%
47,050 $4.05 Million
Q2 2022

Jul 14, 2022

BUY
$83.49 - $94.64 $28,386 - $32,177
340 Added 0.74%
46,345 $4.23 Million
Q1 2022

Apr 28, 2022

BUY
$73.51 - $82.4 $70,569 - $79,104
960 Added 2.13%
46,005 $3.78 Million
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $176,724 - $221,370
2,445 Added 5.74%
45,045 $3.45 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $46,592 - $51,239
650 Added 1.55%
42,600 $3.2 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $134,292 - $148,540
1,910 Added 4.77%
41,950 $3.26 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $19,625 - $23,116
285 Added 0.72%
40,040 $3.09 Million
Q4 2020

Feb 11, 2021

SELL
$71.77 - $79.65 $138,874 - $154,122
-1,935 Reduced 4.64%
39,755 $3.25 Million
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $143,066 - $162,167
1,955 Added 4.92%
41,690 $3.46 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $18,661 - $21,234
265 Added 0.67%
39,735 $3.07 Million
Q1 2020

Apr 30, 2020

SELL
$63.36 - $87.82 $1,457 - $2,019
-23 Reduced 0.06%
39,470 $3.04 Million
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $24,437 - $27,575
315 Added 0.8%
39,493 $3.59 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $237,065 - $258,409
3,116 Added 8.64%
39,178 $3.3 Million
Q2 2019

Aug 09, 2019

BUY
$69.84 - $81.59 $35,269 - $41,202
505 Added 1.42%
36,062 $3.02 Million
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $35,137 - $40,076
505 Added 1.44%
35,557 $2.96 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $68,306 - $79,268
1,047 Added 3.08%
35,052 $2.68 Million
Q3 2018

Oct 12, 2018

BUY
$57.69 - $67.84 $62,305 - $73,267
1,080 Added 3.28%
34,005 $2.41 Million
Q1 2018

May 08, 2018

SELL
$50.96 - $59.23 $311,110 - $361,599
-6,105 Reduced 15.64%
32,925 $1.79 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $120,532 - $143,929
2,335 Added 6.36%
39,030 $2.2 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $39,895 - $42,928
680 Added 1.89%
36,695 $2.35 Million
Q2 2017

Aug 10, 2017

BUY
N/A
36,015
36,015 $2.31 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pittenger & Anderson Inc Portfolio

Follow Pittenger & Anderson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.